HuGE Literature Finder
Records 1-12
Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia.
Cancer chemotherapy and pharmacology 2020 Nov . Al-Sheikh Abrar, Yousef Al-Motassem, Alshamaseen Daniah, Farhad Ra |
Pathway Genes and Metabolites in Thiopurine Therapy in Korean Children with Acute Lymphoblastic Leukemia.
British journal of clinical pharmacology 2019 Mar . Choi Rihwa, Sohn Insuk, Kim Min-Ji, Woo HyeIn, Lee Ji Won, Ma Youngeun, Yi Eun Sang, Koo Hong Hoe, Lee Soo-Yo |
Pancytopenia and Severe Gastrointestinal Toxicities Associated with 5-Fluorouracil in a Patient with Thymidylate Synthase (TYMS) Polymorphism.
Cureus 2016 Sep 8 (9): e798. Wang Bo, Walsh Shannon J, Saif Muhammad |
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
Cancer chemotherapy and pharmacology 2015 Oct . Deenen Maarten J, Meulendijks Didier, Boot Henk, Legdeur Marie-Cecile J C, Beijnen Jos H, Schellens Jan H M, Cats Annemie |
Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.
Inflammatory bowel diseases 2015 Aug . Lee Mi-Na, Kang Ben, Choi So Yoon, Kim Mi Jin, Woo Sook Young, Kim Jong-Won, Choe Yon Ho, Lee Soo-Yo |
Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G>C Substitution in the First 28-bp tandem repeat of the thymidylate synthase 2R Allele.
International journal of cancer. Journal international du cancer 2015 Jul . Meulendijks Didier, Jacobs Bart A W, Aliev Abidin, Pluim Dick, van Werkhoven Erik, Deenen Maarten J, Beijnen Jos H, Cats Annemieke, Schellens Jan H |
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.
Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia.
Pharmacogenetics and genomics 2014 Aug 24 (8): 387-96. Zgheib Nathalie K, Akra-Ismail Maya, Aridi Carol, Mahfouz Rami, Abboud Miguel R, Solh Hassan, Muwakkit Samar |
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer.
The pharmacogenomics journal 2011 Feb 11 (1): 61-71. Glimelius B, Garmo H, Berglund A, Fredriksson L A, Berglund M, Kohnke H, Byström P, Sørbye H, Wadelius |
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy.
British journal of cancer 2010 Aug 103 (4): 581-9. Martinez-Balibrea E, Abad A, Martínez-Cardús A, Ginés A, Valladares M, Navarro M, Aranda E, Marcuello E, Benavides M, Massutí B, Carrato A, Layos L, Manzano J L, Moreno |
Predictive value of Ile105Val polymorphism of the gluthatione-S-transferase P1 in patients with metastatic colorectal cancer (m CRC) treated with the triplet combination of irinotecan, oxaliplatin, and capecitabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15_suppl): 2544. Zarate R N, Rodriguez J, Bandres E, Bitarte N, Ramirez N, Ponz M, Chopitea A, Viudez A, Garcia-Foncillas |
Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients.
Cancer genomics & proteomics 0 8 (5): 255-9. Wong Andrea Li-Ann, Yap Hui-Ling, Yeo Wee-Lee, Soong Richie, Ng Swee-Siang, Wang Ling-Zhi, Cordero Maricel Tiemsim, Yong Wei-Peng, Goh Boon-Cher, Lee Soo-Ch |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: